Thomas Jensen

CIK: 0001888277

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VBIO

Valion Bio, Inc.

Director

ALLR

Allarity Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ALLR
Allarity Therapeutics, Inc.
Jan 28, 2026
Award(A)
Direct
200K shares-
ALLR
Allarity Therapeutics, Inc.
Jan 22, 2025
Award(A)
Direct
396.7K shares-

		Type	Shares	Price		Ownership
Jan 28, 2026	ALLR Allarity Therapeutics, Inc.	Award(A)	200,000	-	$0	Direct
Jan 22, 2025	ALLR Allarity Therapeutics, Inc.	Award(A)	396,734	-	$0	Direct

1-2 of 2 transactions

About Jensen Thomas

Jensen Thomas (SEC CIK 0001888277) files insider reports with the SEC as Director of Valion Bio, Inc. (VBIO) and CEO of Allarity Therapeutics, Inc. (ALLR).

Signal8 holds 3 ownership filings by Jensen Thomas (1 Form 3, 2 Form 4), filed between Jan 24, 2025 and Sep 17, 2026. Those filings report 2 transactions, from Jan 22, 2025 to Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jensen Thomas's filings is in SAN ANTONIO, TX.

Recent filings by Jensen Thomas

Jan 28, 2026: Grant or award of ALLR shares (Form 4, code A).
Jan 22, 2025: Grant or award of ALLR shares (Form 4, code A).

Other insiders filing for Valion Bio, Inc. (VBIO)

Zikria Dean, Interim CEO
Wolf Lisa G, COO & CFO
Malbin Jared David, Director
Lackey Melinda, General Counsel & SVP of Legal

How to read Form 4 transaction codes